|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/02 |
| (11) | Number of the document | 3063173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14799089.9 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/063380 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/066450 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361898309 P | 2013-10-31 | US | |
| 14306220 | 2014-07-31 | EP |
| (72) |
DESLANDES, Antoine, US
GRZEGORZEWSKI, Krzysztof, J., US
OZOUX, Marie-laure, US
TOMKINSON, Blake, US
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | SPECIFIC ANTI-CD38 ANTIBODIES FOR TREATING HUMAN CANCERS |
| SPECIFIC ANTI-CD38 ANTIBODIES FOR TREATING HUMAN CANCERS |